AU2752692A - Imidazopyridines and indolizines as 5-ht4 antagonists - Google Patents

Imidazopyridines and indolizines as 5-ht4 antagonists

Info

Publication number
AU2752692A
AU2752692A AU27526/92A AU2752692A AU2752692A AU 2752692 A AU2752692 A AU 2752692A AU 27526/92 A AU27526/92 A AU 27526/92A AU 2752692 A AU2752692 A AU 2752692A AU 2752692 A AU2752692 A AU 2752692A
Authority
AU
Australia
Prior art keywords
indolizines
imidazopyridines
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27526/92A
Other languages
English (en)
Inventor
Laramie Mary Gaster
Graham Francis Joiner
Francis David King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122623A external-priority patent/GB9122623D0/en
Priority claimed from GB929205427A external-priority patent/GB9205427D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2752692A publication Critical patent/AU2752692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU27526/92A 1991-10-24 1992-10-15 Imidazopyridines and indolizines as 5-ht4 antagonists Abandoned AU2752692A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919122623A GB9122623D0 (en) 1991-10-24 1991-10-24 Pharmaceuticals
GB9122623 1991-10-24
GB9205427 1992-03-12
GB929205427A GB9205427D0 (en) 1992-03-12 1992-03-12 Pharmaceuticals

Publications (1)

Publication Number Publication Date
AU2752692A true AU2752692A (en) 1993-05-21

Family

ID=26299737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27526/92A Abandoned AU2752692A (en) 1991-10-24 1992-10-15 Imidazopyridines and indolizines as 5-ht4 antagonists

Country Status (6)

Country Link
EP (1) EP0609278A1 (ja)
JP (1) JPH07500588A (ja)
AU (1) AU2752692A (ja)
MX (1) MX9206073A (ja)
PT (1) PT100994A (ja)
WO (1) WO1993008187A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
AU4081393A (en) * 1992-05-23 1993-12-30 Smithkline Beecham Plc Medicaments for the treatment of anxiety
AU4350493A (en) * 1992-06-27 1994-01-24 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
EP0664794A1 (en) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
GB9314973D0 (en) * 1993-07-20 1993-09-01 Smithkline Beecham Plc Medicaments
AUPP433398A0 (en) * 1998-06-25 1998-07-16 Australian National University, The Compounds and processes
US7501438B2 (en) 2006-07-07 2009-03-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
US20090325936A1 (en) * 2006-12-20 2009-12-31 Bilodeau Mark T Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
JP2016028016A (ja) * 2012-12-12 2016-02-25 大日本住友製薬株式会社 オキサジアゾール誘導体とその医薬用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0254584B1 (en) * 1986-07-25 1992-10-07 Beecham Group Plc Azabicyclic compounds, process for their preparation, and their pharmaceutical use
EP0289170B1 (en) * 1987-04-25 1993-06-23 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists

Also Published As

Publication number Publication date
MX9206073A (es) 1993-04-01
EP0609278A1 (en) 1994-08-10
JPH07500588A (ja) 1995-01-19
PT100994A (pt) 1994-01-31
WO1993008187A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
AU665877B2 (en) Imidazopyridines
AU4506489A (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
AU650278B2 (en) Biphenyl-substituted bicyclic imidazo derivatives
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
EG20513A (en) Bicyclic tetrahydro pyrazolopyridines
AU3019192A (en) Imidazopyridines
AU7713091A (en) Bicyclic 1-aza-cycloalkanes
HU9403451D0 (en) Imidazopyridine derivatives
AU4123893A (en) Imidazopyridines
IL115667A0 (en) Bicyclic tetrahydro pyrazolopyridines
AU2752692A (en) Imidazopyridines and indolizines as 5-ht4 antagonists
NZ241943A (en) PYRROLO [2,3-b] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
AU5982590A (en) Naphthyridine derivatives
ZA937505B (en) Imidazopyridine derivatives as 5-HT4 receptor antagonists
AU6348794A (en) Imidazopyridine
AU2296092A (en) Muscarinic antagonists
AU3673193A (en) Imidazopyridines
AU5022193A (en) Imidazopyridines
AU6361494A (en) Anhydroretinol and derivatives thereof as antagonists
AU679184B2 (en) New pyridine derivatives as leukcotriene B4 antagonists
AU4720393A (en) Pyrazolopyridine derivatives as angiotensin ii antagonists
AU3377293A (en) Sulphonylbenzyl-substituted imidazopyridines
AU7070494A (en) Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors
AU611283C (en) Pyrazolopyridine type mevalonolactones
GB9116309D0 (en) Bicyclic derivatives